Novartis AG Market Cap 2006-2019 | NVS

Novartis AG market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Novartis AG market cap as of October 16, 2019 is $196.93B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $196.934B $51.900B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $344.992B 15.02
Roche Holding AG (RHHBY) Switzerland $246.683B 0.00
Merck (MRK) United States $216.838B 17.83
Pfizer (PFE) United States $200.777B 11.82
Novo Nordisk (NVO) Denmark $123.207B 21.77
AstraZeneca (AZN) United Kingdom $115.026B 22.25
Sanofi (SNY) France $112.411B 13.81
AbbVie (ABBV) United States $109.053B 8.74
GlaxoSmithKline (GSK) United Kingdom $105.181B 13.22
Eli Lilly (LLY) United States $104.170B 19.44
Bristol-Myers Squibb (BMY) United States $84.340B 11.96
Bayer (BAYRY) Germany $67.293B 9.80
H Lundbeck (HLUYY) Denmark $6.598B 9.52